I was studying systemic lupus erythematous amd I feel the patjo physio

6eedf4d3-721a-4fd7-bb4d-979fbd56d955.jpeg

I was studying systemic lupus erythematous amd I feel the patjo physiology is weird check it for me

analyse_media

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Loading Image

I now have everything needed for a thorough, accurate review. Here is my full analysis:

Your SLE Pathophysiology Notes - Fact Check ✅ / ❌

Your notes are mostly correct but significantly incomplete. The core chain you wrote is valid, but it skips several important steps and contains one minor word error. Here is the full breakdown:

What You Wrote (Transcribed)

The body produces antibodies against nuclear components ↓ These antibodies from immune complexes ↓ Immune complexes deposit in tissues ↓ This causes inflammation and tissue damage.

Issues Found

1. Typo - "from" should be "form" "These antibodies from immune complexes" - you almost certainly meant "form immune complexes." This is just a spelling error, but it changes the meaning entirely if read literally.

2. The chain is correct but very superficial What you wrote is not wrong - it is the simplified, bare-bones version. However, a key question is: where do the autoantigens come from in the first place? Your notes skip the trigger entirely, which is the most "weird" part of SLE that is worth understanding. According to Harrison's Principles of Internal Medicine (2025):

Neutrophils and dying cells release nuclear debris (via apoptosis and NETosis - neutrophil extracellular trap formation)
This debris accumulates because clearance mechanisms fail (deficient complement, deficient DNase)
Dendritic cells present these antigens; plasmacytoid DCs produce Type 1 Interferon (IFN), which amplifies the entire immune response
Autoreactive T cells then help autoreactive B cells produce the autoantibodies (anti-dsDNA, anti-Sm, anti-histone, etc.)
Then your chain kicks in: antibodies form immune complexes → deposit in tissues → inflammation

So the full corrected pathophysiology looks like this:

Complete, Accurate Pathophysiology (per Harrison's & Robbins)

Genetic susceptibility (HLA-DR, complement genes, IRF5, etc.)
+ Environmental triggers (UV light, EBV, silica, hormones)
         ↓
Increased cellular apoptosis/NETosis → nuclear debris released
         ↓
Impaired clearance of debris (↓complement C1q, ↓DNase1L3)
         ↓
Innate immune activation: Plasmacytoid dendritic cells
sense nucleic acids via TLR7/TLR9 → secrete Type I IFN
         ↓
Type I IFN amplifies adaptive immune response
         ↓
Dendritic cells present autoantigens to autoreactive T cells
         ↓
Autoreactive B cells stimulated → produce autoantibodies
(anti-dsDNA, anti-Sm, anti-histone, anti-Ro, anti-La)
         ↓
Autoantibodies + autoantigens → circulating immune complexes
         ↓
Immune complexes deposit in tissues (kidney, skin, joints,
vessels, brain)
         ↓
Complement activation (Classical pathway via C1q)
+ Fc receptor engagement → neutrophil/monocyte recruitment
         ↓
Local inflammation → tissue damage (lupus nephritis,
serositis, CNS disease, cytopenias)

Why It Feels "Weird"

SLE is a Type III hypersensitivity reaction (immune complex-mediated) at its core - Miller's Review of Orthopaedics confirms this directly. But it is unusual because:

The trigger is self-DNA and self-nuclear proteins - the body's own housekeeping debris
The disease is driven largely by a failure to clear apoptotic cells, not by an external pathogen
Type I IFN plays a central amplifying role that most other autoimmune diseases do not depend on this heavily - this is why the IFN signature on a blood test is considered a hallmark of SLE

Your Notes Summary

Element	Correct?	Comment
Antibodies against nuclear components	✅	Correct, especially anti-dsDNA, anti-Sm
Antibodies "from" immune complexes	⚠️	Typo - should be "form"
Immune complexes deposit in tissues	✅	Correct - kidneys, skin, vessels mainly
Causes inflammation and tissue damage	✅	Correct - via complement activation
Missing: source of autoantigens	❌	Apoptosis/NETosis not mentioned
Missing: Type I IFN central role	❌	Key amplifier of the entire cascade
Missing: T cell - B cell cooperation	❌	B cells need T-helper cell signals
Missing: complement activation step	❌	Classical pathway drives much of the damage

Here is the pathogenesis diagram from Harrison's Principles of Internal Medicine (2025) which shows the full picture:

Your notes capture the middle and end of the cascade correctly. For exams, make sure you also learn the upstream steps - the innate immune failure to clear debris and the Type I IFN "accelerant" are frequently tested.

Harrison's Principles of Internal Medicine 22E (2025), Chapter 568
Miller's Review of Orthopaedics 9th Edition, Chapter 1
Andrews' Diseases of the Skin, Chapter 8

I am an occupational therapy ug student in second year it is ny gm gs 5 mark question a part

Got it! You're a 2nd year OT student and this is a General Medicine / General Surgery (GM/GS) 5-mark question. So you need a clean, exam-focused answer - not too deep, but complete enough to score full marks.

Here is a perfect 5-mark answer for the pathophysiology of SLE:

Pathophysiology of Systemic Lupus Erythematosus (SLE)

(5 Marks - GM/GS - OT 2nd Year)

SLE is a chronic autoimmune disease mediated by Type III hypersensitivity reaction (immune complex-mediated).

Step-by-Step Pathophysiology:

Step 1 - Triggering of Autoantigen Release Genetic predisposition combined with environmental triggers (UV light, infections like EBV, hormones) causes increased apoptosis of body cells, releasing nuclear debris (DNA, histones, RNA) into circulation.

Step 2 - Failure of Clearance Normally, this debris is cleared. In SLE, clearance mechanisms are defective (reduced complement C1q, reduced DNase activity), so nuclear material accumulates.

Step 3 - Autoantibody Production The immune system recognizes these nuclear components as foreign. B cells (with T-helper cell signals) produce antinuclear antibodies (ANAs) - particularly:

Anti-dsDNA
Anti-Sm (Smith antigen)
Anti-histone antibodies

Step 4 - Immune Complex Formation These autoantibodies bind to their target antigens, forming circulating immune complexes.

Step 5 - Immune Complex Deposition The complexes deposit in tissues - mainly the kidneys (glomeruli), skin, joints, and blood vessels.

Step 6 - Complement Activation and Inflammation Deposited complexes activate the classical complement pathway → attract neutrophils and monocytes → release inflammatory mediators → causing inflammation and tissue damage.

This leads to the clinical features: lupus nephritis, malar rash, arthritis, serositis, cytopenias, and CNS involvement.

One-Line Summary for Recall:

Defective clearance of nuclear debris → autoantibody production → immune complex deposition in tissues → complement activation → inflammation and organ damage.

Tip for Your Answer Sheet:

Write the 6 steps as numbered points - examiners love structured answers
Mention Type III hypersensitivity - this one line fetches marks
Mention at least 2 autoantibodies (anti-dsDNA and anti-Sm)
End with 2-3 clinical examples (nephritis, malar rash, arthritis)

This covers everything needed for a clean 5/5. Your notes had the right idea - they just needed the upstream steps (Steps 1 and 2) added in. Good luck! 🎯

Create a study guide for SLE clinical features and investigations

Finding Sources

Reading File

Finding Sources

Reading File

Running Command

ls /home/daytona/workspace/ 2>/dev/null || echo "workspace empty or missing"

Running Command

mkdir -p /home/daytona/workspace/sle-study-guide

Writing File

~/sle-study-guide/create_sle_guide.js

const pptxgen = require("pptxgenjs");

let pres = new pptxgen();
pres.layout = 'LAYOUT_WIDE';
pres.title = 'SLE Clinical Features & Investigations - Study Guide';

// ── COLOR PALETTE ──────────────────────────────────────────
const DARK_BG   = "1A1A2E";   // deep navy (title / section headers)
const MID_BG    = "16213E";   // slightly lighter navy
const ACCENT    = "E94560";   // vivid red-pink (headings, icons)
const ACCENT2   = "0F3460";   // medium blue (boxes)
const CARD_BG   = "0D1B2A";   // card background
const WHITE     = "FFFFFF";
const PALE      = "C9D6E3";   // muted light blue for body text
const YELLOW    = "FFD166";   // highlight / mnemonic
const GREEN     = "06D6A0";   // positive / key finding
const ORANGE    = "F4A261";   // warning / important

// ── HELPERS ──────────────────────────────────────────────────
function addSlideBg(slide, color) {
  slide.addShape(pres.ShapeType.rect, { x: 0, y: 0, w: 13.3, h: 7.5, fill: { color } });
}

function sectionBar(slide, title, y = 0) {
  slide.addShape(pres.ShapeType.rect, { x: 0, y, w: 13.3, h: 0.55, fill: { color: ACCENT } });
  slide.addText(title, { x: 0.2, y: y + 0.04, w: 13, h: 0.48, fontSize: 16, bold: true, color: WHITE, valign: "middle", margin: 0 });
}

function card(slide, x, y, w, h, bgColor) {
  slide.addShape(pres.ShapeType.roundRect, {
    x, y, w, h,
    fill: { color: bgColor || CARD_BG },
    line: { color: ACCENT2, width: 1 },
    rectRadius: 0.12
  });
}

function slideNumber(slide, n) {
  slide.addText(`${n}`, { x: 12.8, y: 7.1, w: 0.4, h: 0.3, fontSize: 9, color: "555577", align: "right" });
}

// ── SLIDE 1 – TITLE ──────────────────────────────────────────
{
  let s = pres.addSlide();
  addSlideBg(s, DARK_BG);

  // decorative circles
  s.addShape(pres.ShapeType.ellipse, { x: -1, y: -1, w: 5, h: 5, fill: { color: "E94560", transparency: 85 }, line: { color: "E94560", transparency: 85 } });
  s.addShape(pres.ShapeType.ellipse, { x: 9.5, y: 4, w: 6, h: 6, fill: { color: "0F3460", transparency: 80 }, line: { color: "0F3460", transparency: 80 } });

  s.addText("SYSTEMIC LUPUS ERYTHEMATOSUS", {
    x: 0.6, y: 1.6, w: 12, h: 0.8,
    fontSize: 28, bold: true, color: ACCENT, align: "center", charSpacing: 3
  });
  s.addText("Clinical Features & Investigations", {
    x: 0.6, y: 2.55, w: 12, h: 0.7,
    fontSize: 22, bold: false, color: WHITE, align: "center"
  });

  // divider line
  s.addShape(pres.ShapeType.rect, { x: 3, y: 3.35, w: 7.3, h: 0.04, fill: { color: ACCENT } });

  s.addText("Study Guide for OT 2nd Year  •  GM/GS", {
    x: 0.6, y: 3.55, w: 12, h: 0.45,
    fontSize: 13, color: PALE, align: "center", italic: true
  });

  // badge row
  const badges = ["Multisystem", "Type III HSR", "F > M (9:1)", "Age 20-40 yrs"];
  const bw = 2.5, bx0 = 1.65;
  badges.forEach((b, i) => {
    card(s, bx0 + i * (bw + 0.2), 4.55, bw, 0.6, ACCENT2);
    s.addText(b, { x: bx0 + i * (bw + 0.2) + 0.05, y: 4.55, w: bw, h: 0.6, fontSize: 13, color: YELLOW, bold: true, align: "center", valign: "middle" });
  });

  s.addText("Source: Harrison's Principles of Internal Medicine 22E (2025)  •  Andrews' Diseases of the Skin", {
    x: 0.5, y: 7.1, w: 12.3, h: 0.3, fontSize: 8, color: "445566", align: "center"
  });
}

// ── SLIDE 2 – OVERVIEW ───────────────────────────────────────
{
  let s = pres.addSlide();
  addSlideBg(s, MID_BG);
  sectionBar(s, "OVERVIEW  &  SYSTEMIC MANIFESTATIONS");
  slideNumber(s, 2);

  // left column - definition box
  card(s, 0.3, 0.7, 6, 1.5, "0A1628");
  s.addText("What is SLE?", { x: 0.4, y: 0.75, w: 5.8, h: 0.4, fontSize: 13, bold: true, color: ACCENT });
  s.addText([
    { text: "Chronic, systemic autoimmune disease", options: { breakLine: true } },
    { text: "caused by autoantibodies against nuclear", options: { breakLine: true } },
    { text: "antigens → immune complex deposition.", options: {} }
  ], { x: 0.4, y: 1.15, w: 5.8, h: 0.9, fontSize: 11, color: PALE });

  // epidemiology box
  card(s, 0.3, 2.35, 6, 2.3, "0A1628");
  s.addText("Key Epidemiology", { x: 0.4, y: 2.4, w: 5.8, h: 0.4, fontSize: 13, bold: true, color: GREEN });
  const epi = [
    ["Female : Male", "9 : 1"],
    ["Peak age", "20 - 40 years"],
    ["Higher risk", "African American, Hispanic women"],
    ["Hypersensitivity", "Type III (immune complex)"],
  ];
  epi.forEach(([label, val], i) => {
    s.addText(label + ":", { x: 0.45, y: 2.88 + i * 0.38, w: 2.4, h: 0.35, fontSize: 10.5, color: PALE, bold: true });
    s.addText(val, { x: 2.85, y: 2.88 + i * 0.38, w: 3.2, h: 0.35, fontSize: 10.5, color: YELLOW });
  });

  // right column - constitutional symptoms
  card(s, 6.8, 0.7, 6.2, 3.95, "0A1628");
  s.addText("Constitutional / Systemic Symptoms", { x: 6.9, y: 0.75, w: 5.9, h: 0.4, fontSize: 13, bold: true, color: ORANGE });
  const sys = [
    "Fever (common during flares)",
    "Fatigue (most frequent complaint, affects QoL)",
    "Unintentional weight loss",
    "Anorexia",
    "Brain fog / cognitive slowing",
    "Lymphadenopathy",
    "Approximately 15% have mild disease only"
  ];
  sys.forEach((item, i) => {
    s.addText("▸  " + item, { x: 6.9, y: 1.25 + i * 0.47, w: 5.9, h: 0.42, fontSize: 10.5, color: PALE });
  });

  // bottom note
  card(s, 0.3, 4.75, 12.7, 0.6, "1C2E40");
  s.addText("⚠  Disease course: relapsing-remitting flares. Majority require ongoing therapy. Goal = low disease activity (SLEDAI ≤ 4) or remission.", {
    x: 0.5, y: 4.78, w: 12.5, h: 0.54, fontSize: 10, color: YELLOW, italic: true, valign: "middle"
  });
  slideNumber(s, 2);
}

// ── SLIDE 3 – SKIN MANIFESTATIONS ────────────────────────────
{
  let s = pres.addSlide();
  addSlideBg(s, MID_BG);
  sectionBar(s, "CUTANEOUS MANIFESTATIONS  (Skin - 80% of patients)");
  slideNumber(s, 3);

  const skinData = [
    {
      title: "ACUTE Cutaneous LE (ACLE)",
      color: ACCENT,
      items: [
        "Malar (butterfly) rash — cheeks + nasal bridge, SPARES nasolabial folds",
        "Photosensitive, slightly raised, erythematous",
        "Can resemble rosacea but nasolabial sparing distinguishes SLE",
        "Also: bullous ACLE, toxic epidermal necrolysis variant"
      ]
    },
    {
      title: "SUBACUTE Cutaneous LE (SCLE)",
      color: ORANGE,
      items: [
        "Photosensitive, non-scarring rash",
        "Flat, red-rimmed annular or psoriasiform lesions",
        "Associated with anti-Ro (SSA) antibodies"
      ]
    },
    {
      title: "CHRONIC Cutaneous LE",
      color: GREEN,
      items: [
        "Discoid LE (DLE) — most common chronic form",
        "Rough, circular, slightly raised, hyperpigmented",
        "Atrophic, depigmented centre + erythematous rim",
        "Other: hypertrophic lupus, lupus panniculitis, tumid lupus"
      ]
    },
    {
      title: "Non-specific Skin Features",
      color: YELLOW,
      items: [
        "Non-scarring alopecia (hair thinning/loss)",
        "Oral / nasal mucosal ulcers (painful or painless)",
        "Raynaud's phenomenon: triphasic color change (white→blue→red)",
        "Leukocytoclastic vasculitis, urticarial vasculitis"
      ]
    }
  ];

  const cols = [0.25, 6.75];
  const rows = [0.65, 3.8];
  skinData.forEach((sec, i) => {
    const cx = cols[i % 2];
    const cy = rows[Math.floor(i / 2)];
    card(s, cx, cy, 6.3, 3, CARD_BG);
    s.addShape(pres.ShapeType.rect, { x: cx, y: cy, w: 6.3, h: 0.42, fill: { color: ACCENT2 } });
    s.addText(sec.title, { x: cx + 0.1, y: cy + 0.04, w: 6.1, h: 0.36, fontSize: 11.5, bold: true, color: sec.color, valign: "middle", margin: 0 });
    sec.items.forEach((item, j) => {
      s.addText("•  " + item, { x: cx + 0.15, y: cy + 0.52 + j * 0.56, w: 6.0, h: 0.52, fontSize: 9.8, color: PALE });
    });
  });

  // bottom mnemonic strip
  s.addShape(pres.ShapeType.rect, { x: 0, y: 7.1, w: 13.3, h: 0.4, fill: { color: DARK_BG } });
  s.addText("★  EXAM TIP: Malar rash SPARES nasolabial folds (unlike rosacea). Discoid = scarring + hyperpigmented. Anti-Ro → SCLE.", {
    x: 0.2, y: 7.12, w: 13, h: 0.36, fontSize: 9.5, color: YELLOW, bold: true
  });
}

// ── SLIDE 4 – MUSCULOSKELETAL + RENAL ────────────────────────
{
  let s = pres.addSlide();
  addSlideBg(s, MID_BG);
  sectionBar(s, "MUSCULOSKELETAL  &  RENAL MANIFESTATIONS");
  slideNumber(s, 4);

  // MSK
  card(s, 0.25, 0.65, 6.3, 3.15, CARD_BG);
  s.addText("🦴  Musculoskeletal", { x: 0.35, y: 0.7, w: 6, h: 0.45, fontSize: 14, bold: true, color: ORANGE });
  const msk = [
    "Arthralgia / myalgia — most common complaint",
    "Polyarthritis: wrists, MCPs, PIPs, knees",
    "Non-erosive (unlike RA) — may show on MRI",
    "Jaccoud arthropathy: reversible joint deformity from ligament damage",
    "'Rhupus' = RA + SLE overlap",
    "Avascular necrosis (esp. hip/shoulder) — steroid-related",
    "Inflammatory myopathy: proximal weakness, ↑CK, ↑aldolase"
  ];
  msk.forEach((item, i) => {
    s.addText("▸  " + item, { x: 0.35, y: 1.22 + i * 0.38, w: 6.05, h: 0.36, fontSize: 9.8, color: PALE });
  });

  // Renal
  card(s, 6.75, 0.65, 6.3, 3.15, CARD_BG);
  s.addText("🫘  Renal (Lupus Nephritis)", { x: 6.85, y: 0.7, w: 6, h: 0.45, fontSize: 14, bold: true, color: ACCENT });
  const renal = [
    "~35% of SLE patients develop nephritis",
    "More severe in non-white patients",
    "May be ASYMPTOMATIC → screen every 3 months",
    "Screen with: random urine protein:creatinine ratio (UPCR)",
    "Renal biopsy if UPCR > 0.5 or declining eGFR",
    "Class III/IV = proliferative GN = aggressive therapy",
    "Class V = membranous = nephrotic syndrome",
    "Markers: ↑anti-dsDNA + ↓C3/C4 = impending nephritis"
  ];
  renal.forEach((item, i) => {
    s.addText("▸  " + item, { x: 6.85, y: 1.22 + i * 0.38, w: 6.05, h: 0.36, fontSize: 9.8, color: PALE });
  });

  // WHO classes table
  card(s, 0.25, 3.9, 12.8, 2.9, "0A1628");
  s.addText("Lupus Nephritis Classes (ISN/RPS)", { x: 0.4, y: 3.95, w: 12, h: 0.4, fontSize: 13, bold: true, color: GREEN });
  const classes = [
    ["Class I", "Minimal mesangial", "No treatment needed"],
    ["Class II", "Mesangial proliferative", "Conservative"],
    ["Class III", "Focal proliferative GN (<50% glomeruli)", "Aggressive immunosuppression"],
    ["Class IV", "Diffuse proliferative GN (≥50% glomeruli)", "Aggressive immunosuppression ← worst"],
    ["Class V", "Membranous GN", "Treat like III/IV if combined; nephrotic"],
  ];
  const colXs = [0.35, 1.85, 4.85, 8.6];
  const colWs = [1.4, 2.9, 3.65, 4.4];
  const headers = ["Class", "Type", "Pathology", "Management"];
  headers.forEach((h, ci) => {
    s.addText(h, { x: colXs[ci], y: 4.4, w: colWs[ci], h: 0.32, fontSize: 9.5, bold: true, color: YELLOW });
  });
  classes.forEach((row, ri) => {
    const rowColor = ri % 2 === 0 ? "0D1B2A" : "111E30";
    const cols_data = [row[0], row[1], row[2]];
    const xs = [colXs[0], colXs[1], colXs[2]];
    const ws = [colWs[0], colWs[1], colWs[2] + colWs[3]];
    xs.forEach((x, ci) => {
      s.addText(cols_data[ci], { x, y: 4.77 + ri * 0.38, w: ws[ci], h: 0.35, fontSize: 9, color: ci === 0 ? ACCENT : PALE });
    });
  });

  slideNumber(s, 4);
}

// ── SLIDE 5 – CNS + HAEMATOLOGICAL + CARDIOPULMONARY ─────────
{
  let s = pres.addSlide();
  addSlideBg(s, MID_BG);
  sectionBar(s, "NERVOUS SYSTEM  •  HAEMATOLOGICAL  •  CARDIOPULMONARY MANIFESTATIONS");
  slideNumber(s, 5);

  // CNS
  card(s, 0.25, 0.65, 4.15, 6.2, CARD_BG);
  s.addText("🧠  CNS / Neuropsychiatric", { x: 0.35, y: 0.7, w: 3.9, h: 0.42, fontSize: 12, bold: true, color: ACCENT });
  const cns = [
    "Brain fog / cognitive dysfunction (most common diffuse symptom)",
    "Severe headache (migraine-like)",
    "Seizures (any type)",
    "Acute psychosis / confusional state",
    "Transverse myelitis",
    "Mononeuritis multiplex",
    "Cerebrovascular disease / stroke (esp. with APLA)",
    "Peripheral neuropathy",
    "Cranial nerve palsies",
    "Optic neuritis",
    "Chorea"
  ];
  cns.forEach((item, i) => {
    s.addText("▸  " + item, { x: 0.32, y: 1.22 + i * 0.47, w: 3.95, h: 0.44, fontSize: 9.2, color: PALE });
  });

  // Haematological
  card(s, 4.6, 0.65, 4.1, 3.0, CARD_BG);
  s.addText("🩸  Haematological", { x: 4.7, y: 0.7, w: 3.9, h: 0.42, fontSize: 12, bold: true, color: ORANGE });
  const haem = [
    "Haemolytic anaemia (Coombs positive)",
    "Leukopenia / lymphopenia",
    "Thrombocytopenia",
    "Antiphospholipid antibodies (APLA) → thrombosis, recurrent miscarriage",
    "Lupus anticoagulant → paradoxically thrombotic (not protective)",
    "Elevated ESR (not CRP usually)"
  ];
  haem.forEach((item, i) => {
    s.addText("▸  " + item, { x: 4.7, y: 1.22 + i * 0.44, w: 3.85, h: 0.42, fontSize: 9.2, color: PALE });
  });

  // Cardiopulmonary
  card(s, 4.6, 3.8, 4.1, 3.05, CARD_BG);
  s.addText("🫀  Cardiopulmonary", { x: 4.7, y: 3.85, w: 3.9, h: 0.42, fontSize: 12, bold: true, color: GREEN });
  const cardio = [
    "Pericarditis (most common cardiac feature)",
    "Myocarditis → heart failure",
    "Libman-Sacks endocarditis (sterile verrucous)",
    "Pleuritis / pleural effusion (most common chest feature)",
    "Pneumonitis (acute lupus pneumonitis)",
    "Pulmonary arterial hypertension",
    "Shrinking lung syndrome"
  ];
  cardio.forEach((item, i) => {
    s.addText("▸  " + item, { x: 4.7, y: 4.35 + i * 0.38, w: 3.85, h: 0.36, fontSize: 9.2, color: PALE });
  });

  // GI / Other
  card(s, 8.9, 0.65, 4.15, 6.2, CARD_BG);
  s.addText("🔬  GI & Other Organs", { x: 9.0, y: 0.7, w: 3.9, h: 0.42, fontSize: 12, bold: true, color: YELLOW });
  const other = [
    "Hepatomegaly / splenomegaly",
    "Serositis (peritonitis)",
    "Nausea, abdominal pain, diarrhoea",
    "Mesenteric vasculitis (rare but serious)",
    "",
    "Eyes:",
    "Keratoconjunctivitis sicca (sicca syndrome)",
    "Retinal vasculitis",
    "Episcleritis",
    "",
    "Glands:",
    "Parotid enlargement (overlap with Sjogren's)",
    "Secondary Sjogren's syndrome (30%)",
  ];
  other.forEach((item, i) => {
    if (item === "") return;
    s.addText((item.endsWith(":") ? item : "▸  " + item), {
      x: 9.0, y: 1.22 + i * 0.42, w: 3.95, h: 0.4,
      fontSize: 9.2, color: item.endsWith(":") ? ORANGE : PALE,
      bold: item.endsWith(":")
    });
  });

  slideNumber(s, 5);
}

// ── SLIDE 6 – ACR / SLICC CRITERIA ───────────────────────────
{
  let s = pres.addSlide();
  addSlideBg(s, MID_BG);
  sectionBar(s, "DIAGNOSTIC CRITERIA  —  ACR 1997  &  SLICC 2012");
  slideNumber(s, 6);

  // ACR box
  card(s, 0.25, 0.65, 8.1, 6.2, CARD_BG);
  s.addText("ACR 1997 Criteria  (≥ 4 of 11 = SLE)", { x: 0.35, y: 0.7, w: 7.8, h: 0.45, fontSize: 13, bold: true, color: ACCENT });

  const acr = [
    ["1", "Malar rash", "Butterfly rash across cheeks"],
    ["2", "Discoid rash", "Scarring, hyperpigmented lesions"],
    ["3", "Photosensitivity", "UV-induced rash"],
    ["4", "Oral ulcers", "Usually painless"],
    ["5", "Arthritis", "Non-erosive, ≥2 joints"],
    ["6", "Serositis", "Pleuritis or pericarditis"],
    ["7", "Renal disorder", "Proteinuria >0.5 g/day or casts"],
    ["8", "Neurologic", "Seizures or psychosis (no other cause)"],
    ["9", "Haematologic", "Haemolytic anaemia, leukopenia, thrombocytopenia"],
    ["10", "Immunologic", "Anti-dsDNA, anti-Sm, APLA, false +ve VDRL"],
    ["11", "ANA", "Positive in absence of drug-induced lupus"],
  ];
  acr.forEach((row, i) => {
    const bg = i % 2 === 0 ? "0D1B2A" : "111E30";
    card(s, 0.32, 1.22 + i * 0.47, 7.93, 0.44, bg);
    s.addText(row[0], { x: 0.38, y: 1.24 + i * 0.47, w: 0.35, h: 0.4, fontSize: 10, bold: true, color: YELLOW, align: "center" });
    s.addText(row[1], { x: 0.8, y: 1.24 + i * 0.47, w: 2.5, h: 0.4, fontSize: 10, bold: true, color: ORANGE });
    s.addText(row[2], { x: 3.4, y: 1.24 + i * 0.47, w: 4.8, h: 0.4, fontSize: 9.5, color: PALE });
  });

  // SLICC box
  card(s, 8.6, 0.65, 4.45, 6.2, CARD_BG);
  s.addText("SLICC 2012 Criteria", { x: 8.7, y: 0.7, w: 4.2, h: 0.45, fontSize: 13, bold: true, color: GREEN });
  s.addText("Requires ≥4 criteria (at least 1 clinical + 1 immunologic) OR biopsy-proven lupus nephritis + ANA or anti-dsDNA", {
    x: 8.7, y: 1.2, w: 4.2, h: 0.75, fontSize: 9.8, color: PALE
  });
  s.addText("SLICC Clinical Criteria (11):", { x: 8.7, y: 2.0, w: 4.2, h: 0.35, fontSize: 10.5, bold: true, color: ORANGE });
  const sliccClin = ["Acute cutaneous lupus", "Chronic cutaneous lupus", "Oral ulcers", "Non-scarring alopecia", "Arthritis", "Serositis", "Renal (UPCR >500 mg/g or RBC casts)", "Neurologic", "Haemolytic anaemia", "Leukopenia / lymphopenia", "Thrombocytopenia"];
  sliccClin.forEach((item, i) => {
    s.addText("▸  " + item, { x: 8.7, y: 2.4 + i * 0.31, w: 4.2, h: 0.29, fontSize: 9, color: PALE });
  });
  s.addText("SLICC Immunologic Criteria (6):", { x: 8.7, y: 5.84, w: 4.2, h: 0.35, fontSize: 10.5, bold: true, color: ORANGE });
  const sliccImm = ["ANA", "Anti-dsDNA", "Anti-Sm", "APLA", "Low complement (C3/C4/CH50)", "Direct Coombs test +ve"];
  sliccImm.forEach((item, i) => {
    s.addText("▸  " + item, { x: 8.7, y: 6.22 + i * 0.22, w: 4.2, h: 0.21, fontSize: 8.5, color: PALE });
  });

  slideNumber(s, 6);
}

// ── SLIDE 7 – INVESTIGATIONS ─────────────────────────────────
{
  let s = pres.addSlide();
  addSlideBg(s, MID_BG);
  sectionBar(s, "INVESTIGATIONS");
  slideNumber(s, 7);

  // Immunology
  card(s, 0.25, 0.65, 6.3, 4.0, CARD_BG);
  s.addText("🔬  Immunological / Serological Tests", { x: 0.35, y: 0.7, w: 6.0, h: 0.42, fontSize: 12.5, bold: true, color: ACCENT });
  const immuno = [
    ["ANA (Antinuclear Antibody)", "Best SCREENING test", "Positive in 95% of SLE"],
    ["Anti-dsDNA", "HIGH SPECIFICITY", "Correlates with disease activity + nephritis; ↑ in flare"],
    ["Anti-Sm (Smith antigen)", "HIGHLY SPECIFIC", "Not common but diagnostic; does not correlate with activity"],
    ["Anti-histone", "Drug-induced lupus", "Positive in drug-induced SLE"],
    ["Anti-Ro (SSA)", "SCLE + neonatal lupus", "Associated with photosensitive SCLE"],
    ["Anti-La (SSB)", "Secondary Sjogren's", "Often with anti-Ro"],
    ["APLA (anticardiolipin, anti-β2GPI, LA)", "Thrombosis risk", "Associated with stroke, DVT, recurrent miscarriage"],
  ];
  immuno.forEach((row, i) => {
    s.addText(row[0], { x: 0.35, y: 1.18 + i * 0.49, w: 2.5, h: 0.44, fontSize: 9, bold: true, color: YELLOW });
    s.addText(row[1], { x: 2.9, y: 1.18 + i * 0.49, w: 1.5, h: 0.44, fontSize: 8.5, color: GREEN, bold: true });
    s.addText(row[2], { x: 4.45, y: 1.18 + i * 0.49, w: 2.0, h: 0.44, fontSize: 8.5, color: PALE });
  });

  // Complement
  card(s, 0.25, 4.75, 6.3, 2.15, CARD_BG);
  s.addText("Complement Levels", { x: 0.35, y: 4.8, w: 6.0, h: 0.4, fontSize: 12.5, bold: true, color: ORANGE });
  const comp = [
    ["C3, C4, CH50", "↓ DECREASED in active disease", "Consumed by immune complex formation"],
    ["↓C3 + ↓C4 + ↑anti-dsDNA", "= Active lupus nephritis marker", "Monitor quarterly"],
  ];
  comp.forEach((row, i) => {
    s.addText(row[0], { x: 0.35, y: 5.28 + i * 0.5, w: 2.2, h: 0.45, fontSize: 9.5, bold: true, color: YELLOW });
    s.addText(row[1], { x: 2.6, y: 5.28 + i * 0.5, w: 1.8, h: 0.45, fontSize: 9, color: ACCENT });
    s.addText(row[2], { x: 4.45, y: 5.28 + i * 0.5, w: 2.0, h: 0.45, fontSize: 9, color: PALE });
  });

  // Routine blood + urine
  card(s, 6.8, 0.65, 6.25, 3.0, CARD_BG);
  s.addText("🩸  Haematology & Biochemistry", { x: 6.9, y: 0.7, w: 6.0, h: 0.42, fontSize: 12.5, bold: true, color: GREEN });
  const blood = [
    "CBC: Anaemia (haemolytic or chronic disease), leukopenia, lymphopenia, thrombocytopenia",
    "ESR: Raised (often high even between flares)",
    "CRP: Usually NORMAL or mildly elevated in SLE flare (unlike bacterial infection where CRP is markedly ↑)",
    "LFTs: May be abnormal in hepatic involvement",
    "Serum creatinine + eGFR: Renal monitoring",
    "Urinalysis: Proteinuria, haematuria, RBC casts (active nephritis)",
    "UPCR (urine protein:creatinine ratio): Screen every 3 months"
  ];
  blood.forEach((item, i) => {
    s.addText("▸  " + item, { x: 6.9, y: 1.2 + i * 0.44, w: 6.0, h: 0.42, fontSize: 9.2, color: PALE });
  });

  // Imaging
  card(s, 6.8, 3.75, 6.25, 1.55, CARD_BG);
  s.addText("📡  Imaging", { x: 6.9, y: 3.8, w: 6.0, h: 0.4, fontSize: 12.5, bold: true, color: YELLOW });
  const imaging = [
    "CXR / CT Chest: Pleural effusion, pericardial effusion, pneumonitis",
    "Echocardiography: Libman-Sacks endocarditis, pericardial effusion, PAH",
    "MRI Brain: Neuropsychiatric lupus — cerebral atrophy, white matter lesions",
    "MRI / Ultrasound joints: Erosive changes (more sensitive than X-ray)"
  ];
  imaging.forEach((item, i) => {
    s.addText("▸  " + item, { x: 6.9, y: 4.28 + i * 0.38, w: 6.0, h: 0.36, fontSize: 9.2, color: PALE });
  });

  // Biopsy
  card(s, 6.8, 5.4, 6.25, 1.4, CARD_BG);
  s.addText("🔎  Biopsy", { x: 6.9, y: 5.45, w: 6.0, h: 0.38, fontSize: 12.5, bold: true, color: ORANGE });
  const biopsy = [
    "Renal biopsy: Indicated if UPCR >0.5 or ↓eGFR → classify nephritis (I-V)",
    "Skin biopsy: Lupus band test (immunofluorescence) — IgG, IgM, C3 deposits at DEJ",
    "Muscle biopsy: If inflammatory myopathy suspected"
  ];
  biopsy.forEach((item, i) => {
    s.addText("▸  " + item, { x: 6.9, y: 5.88 + i * 0.34, w: 6.0, h: 0.32, fontSize: 9.2, color: PALE });
  });

  slideNumber(s, 7);
}

// ── SLIDE 8 – AUTOANTIBODY CHEAT SHEET ───────────────────────
{
  let s = pres.addSlide();
  addSlideBg(s, MID_BG);
  sectionBar(s, "AUTOANTIBODY  QUICK-REFERENCE  CHEAT SHEET  ★  HIGH-YIELD FOR EXAMS");
  slideNumber(s, 8);

  const antibodies = [
    { ab: "ANA", sens: "95%", spec: "Low", assoc: "Best screening test. Positive in most connective tissue diseases. NOT specific for SLE.", color: PALE },
    { ab: "Anti-dsDNA", sens: "60-70%", spec: "HIGH", assoc: "SPECIFIC for SLE. Titre CORRELATES with disease activity and nephritis. Monitor to detect flares.", color: ACCENT },
    { ab: "Anti-Sm", sens: "20-30%", spec: "HIGHEST", assoc: "MOST SPECIFIC for SLE. Does NOT correlate with disease activity. Diagnostic if positive.", color: GREEN },
    { ab: "Anti-histone", sens: "60-70%", spec: "Moderate", assoc: "Drug-induced lupus (procainamide, hydralazine, isoniazid, methyldopa). Rare in true SLE.", color: ORANGE },
    { ab: "Anti-Ro (SSA)", sens: "30%", spec: "Moderate", assoc: "SCLE, neonatal lupus, congenital heart block. Also Sjogren's syndrome.", color: YELLOW },
    { ab: "Anti-La (SSB)", sens: "20%", spec: "Moderate", assoc: "Often with anti-Ro. Secondary Sjogren's syndrome.", color: YELLOW },
    { ab: "Anti-phospholipid\n(APLA)", sens: "30-40%", spec: "Moderate", assoc: "Antiphospholipid syndrome: arterial/venous thrombosis, recurrent pregnancy loss, thrombocytopenia.", color: ORANGE },
    { ab: "Anti-C1q", sens: "Low", spec: "Moderate", assoc: "Particularly associated with lupus nephritis and low complement.", color: PALE },
    { ab: "Anti-RNP (U1-RNP)", sens: "30%", spec: "Low", assoc: "High titres → Mixed Connective Tissue Disease (MCTD). Also seen in SLE overlap.", color: PALE },
    { ab: "Lupus anticoagulant", sens: "~30%", spec: "High", assoc: "Part of APLA. Paradoxically THROMBOTIC (not anticoagulant!). Detected by DRVVT / APTT.", color: ACCENT },
  ];

  const colXs = [0.25, 1.55, 2.5, 3.45, 5.7];
  const colWs = [1.25, 0.95, 0.95, 2.2, 7.3];
  const headers2 = ["Antibody", "Sensitivity", "Specificity", "Clinical Association", ""];
  headers2.forEach((h, ci) => {
    if (ci < 4) s.addText(h, { x: colXs[ci], y: 0.63, w: colWs[ci], h: 0.36, fontSize: 10, bold: true, color: YELLOW });
  });
  // full width "notes" header
  s.addText("Key Clinical Significance", { x: colXs[3], y: 0.63, w: 12.8 - colXs[3], h: 0.36, fontSize: 10, bold: true, color: YELLOW });

  antibodies.forEach((row, i) => {
    const rowBg = i % 2 === 0 ? "0D1B2A" : "111E30";
    card(s, 0.22, 1.03 + i * 0.62, 12.86, 0.58, rowBg);
    s.addText(row.ab, { x: colXs[0], y: 1.06 + i * 0.62, w: colWs[0], h: 0.52, fontSize: 9.5, bold: true, color: row.color, valign: "middle" });
    s.addText(row.sens, { x: colXs[1], y: 1.06 + i * 0.62, w: colWs[1], h: 0.52, fontSize: 9, color: PALE, valign: "middle", align: "center" });
    s.addText(row.spec, { x: colXs[2], y: 1.06 + i * 0.62, w: colWs[2], h: 0.52, fontSize: 9, color: row.spec === "HIGHEST" ? GREEN : row.spec === "HIGH" ? ACCENT : PALE, bold: row.spec.includes("HIGH"), valign: "middle", align: "center" });
    s.addText(row.assoc, { x: colXs[3], y: 1.06 + i * 0.62, w: 8.8, h: 0.52, fontSize: 9, color: PALE, valign: "middle" });
  });

  slideNumber(s, 8);
}

// ── SLIDE 9 – MEMORY MNEMONICS ───────────────────────────────
{
  let s = pres.addSlide();
  addSlideBg(s, DARK_BG);
  sectionBar(s, "MEMORY AIDS  &  EXAM TIPS  ★  FOR 5-MARK QUESTIONS");
  slideNumber(s, 9);

  // SOAP BRAIN MD mnemonic
  card(s, 0.25, 0.65, 7.5, 6.25, "0A1628");
  s.addText('"SOAP BRAIN MD"  —  ACR Criteria Mnemonic', {
    x: 0.4, y: 0.7, w: 7.2, h: 0.45, fontSize: 13, bold: true, color: YELLOW
  });
  const soap = [
    { letter: "S", word: "Serositis", detail: "Pleuritis / pericarditis" },
    { letter: "O", word: "Oral ulcers", detail: "Painless usually" },
    { letter: "A", word: "Arthritis", detail: "Non-erosive, ≥2 joints" },
    { letter: "P", word: "Photosensitivity", detail: "UV-induced rash" },
    { letter: "B", word: "Blood disorders", detail: "Anaemia, leukopenia, thrombocytopenia" },
    { letter: "R", word: "Renal disorder", detail: "Proteinuria, casts" },
    { letter: "A", word: "ANA positive", detail: "Screening test" },
    { letter: "I", word: "Immunologic", detail: "Anti-dsDNA, anti-Sm, APLA" },
    { letter: "N", word: "Neurologic", detail: "Seizures, psychosis" },
    { letter: "M", word: "Malar rash", detail: "Butterfly rash" },
    { letter: "D", word: "Discoid rash", detail: "Scarring, hyperpigmented" },
  ];
  soap.forEach((item, i) => {
    s.addText(item.letter, { x: 0.35, y: 1.22 + i * 0.47, w: 0.35, h: 0.42, fontSize: 16, bold: true, color: ACCENT, align: "center" });
    s.addText(item.word, { x: 0.78, y: 1.22 + i * 0.47, w: 2.4, h: 0.42, fontSize: 10.5, bold: true, color: ORANGE });
    s.addText("→  " + item.detail, { x: 3.22, y: 1.22 + i * 0.47, w: 4.3, h: 0.42, fontSize: 10, color: PALE });
  });

  // Key tips
  card(s, 8.0, 0.65, 5.0, 6.25, "0A1628");
  s.addText("⭐  High-Yield Exam Facts", { x: 8.1, y: 0.7, w: 4.7, h: 0.45, fontSize: 13, bold: true, color: GREEN });
  const tips = [
    ["ANA", "Best SCREEN (95% sensitive)"],
    ["Anti-dsDNA", "Tracks DISEASE ACTIVITY"],
    ["Anti-Sm", "MOST SPECIFIC for SLE"],
    ["Anti-histone", "DRUG-INDUCED lupus"],
    ["Anti-Ro", "SCLE + Neonatal lupus"],
    ["C3/C4 ↓", "Active disease / nephritis"],
    ["ESR ↑, CRP normal", "Classic in SLE flare"],
    ["Malar rash", "SPARES nasolabial folds"],
    ["Renal screen", "Every 3 months (urine UPCR)"],
    ["Class IV nephritis", "Worst prognosis"],
    ["Lupus anticoagulant", "Thrombotic, NOT protective"],
    ["APLA + pregnancy", "Recurrent miscarriage"],
    ["F:M ratio", "9:1 (peak age 20-40)"],
  ];
  tips.forEach((tip, i) => {
    s.addText(tip[0] + ":", { x: 8.1, y: 1.22 + i * 0.4, w: 2.0, h: 0.37, fontSize: 9.5, bold: true, color: YELLOW });
    s.addText(tip[1], { x: 10.15, y: 1.22 + i * 0.4, w: 2.7, h: 0.37, fontSize: 9.5, color: PALE });
  });

  slideNumber(s, 9);
}

// ── SLIDE 10 – SUMMARY ───────────────────────────────────────
{
  let s = pres.addSlide();
  addSlideBg(s, DARK_BG);

  // decorative shapes
  s.addShape(pres.ShapeType.ellipse, { x: -1, y: 4, w: 5, h: 5, fill: { color: ACCENT, transparency: 88 }, line: { color: ACCENT, transparency: 88 } });
  s.addShape(pres.ShapeType.ellipse, { x: 10, y: -1, w: 6, h: 6, fill: { color: ACCENT2, transparency: 82 }, line: { color: ACCENT2, transparency: 82 } });

  s.addText("SLE — SUMMARY CARD", {
    x: 0.5, y: 0.4, w: 12.3, h: 0.7, fontSize: 24, bold: true, color: ACCENT, align: "center", charSpacing: 4
  });

  const summary = [
    { label: "Definition", text: "Chronic autoimmune disease, Type III hypersensitivity, multisystem" },
    { label: "Who gets it", text: "Women 9:1, age 20-40, African American / Hispanic higher risk" },
    { label: "Skin", text: "Malar rash (spares nasolabial), discoid, SCLE, alopecia, oral ulcers, Raynaud's" },
    { label: "MSK", text: "Non-erosive polyarthritis, Jaccoud arthropathy, avascular necrosis" },
    { label: "Renal", text: "~35%, class III/IV worst, screen UPCR every 3 months" },
    { label: "CNS", text: "Brain fog, seizures, psychosis, stroke (esp. APLA), transverse myelitis" },
    { label: "Haematology", text: "Haemolytic anaemia, leukopenia, thrombocytopenia, APLA" },
    { label: "Heart/Lung", text: "Pericarditis, Libman-Sacks, pleuritis, lupus pneumonitis" },
    { label: "Key tests", text: "ANA (screen) → anti-dsDNA + anti-Sm + complement + UPCR + CBC" },
    { label: "Diagnosis", text: "ACR: ≥4/11 criteria  |  SLICC: ≥4 (1 clinical + 1 immunologic)" },
    { label: "Monitoring", text: "Anti-dsDNA titre + C3/C4 every visit, UPCR quarterly, eye exam yearly (HCQ)" },
  ];

  summary.forEach((item, i) => {
    const col = i < 6 ? 0 : 1;
    const row = i < 6 ? i : i - 6;
    const x = col === 0 ? 0.25 : 6.8;
    const y = 1.2 + row * 1.0;
    card(s, x, y, 6.3, 0.88, "0D1B2A");
    s.addText(item.label, { x: x + 0.12, y: y + 0.04, w: 1.6, h: 0.4, fontSize: 10, bold: true, color: YELLOW });
    s.addText(item.text, { x: x + 0.12, y: y + 0.44, w: 6.0, h: 0.42, fontSize: 9.5, color: PALE });
  });

  s.addText("Study Guide compiled from Harrison's Internal Medicine 22E (2025)  •  Andrews' Diseases of the Skin  •  Firestein & Kelley's Rheumatology  •  Miller's Review of Orthopaedics", {
    x: 0.5, y: 7.2, w: 12.3, h: 0.25, fontSize: 7.5, color: "334455", align: "center"
  });
}

// ── WRITE FILE ────────────────────────────────────────────────
pres.writeFile({ fileName: "/home/daytona/workspace/sle-study-guide/SLE_Study_Guide_OT2ndYear.pptx" })
  .then(() => console.log("SUCCESS: SLE Study Guide created."))
  .catch(e => console.error("ERROR:", e));

Running Command

cd /home/daytona/workspace/sle-study-guide && node create_sle_guide.js

Running Command

ls -lh /home/daytona/workspace/sle-study-guide/

Your SLE Study Guide is ready! Download it here:

SLE Study Guide OT2ndYear

Presentation · PPTX

Here is what's inside the 10-slide guide (designed in a dark navy + red theme for easy reading):

Slide	Content
1	Title slide with key facts (F:M ratio, age, hypersensitivity type)
2	Overview, epidemiology, constitutional symptoms
3	Cutaneous manifestations - ACLE, SCLE, Chronic, Non-specific
4	Musculoskeletal + Renal with the ISN/RPS nephritis class table
5	CNS / Neuropsychiatric + Haematological + Cardiopulmonary + GI
6	Full ACR 1997 (all 11 criteria) + SLICC 2012 side by side
7	Complete Investigations - serology, blood tests, imaging, biopsy
8	Autoantibody Cheat Sheet with sensitivity, specificity, and clinical meaning
9	"SOAP BRAIN MD" mnemonic for ACR criteria + high-yield exam tips
10	Summary card - one-stop revision before exams

All content sourced from Harrison's 22E (2025), Andrews' Diseases of the Skin, Firestein & Kelley's Rheumatology, and Miller's Review of Orthopaedics.

This is a shared conversation. Sign in to Orris to start your own chat.